These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37940891)

  • 21. [Association of human papillomavirus infection with other microbial pathogens in gynecology].
    Zheng MY; Zhao HL; Di JP; Lin G; Lin Y; Lin X; Zheng MQ
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jun; 45(6):424-8. PubMed ID: 21029592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colposcopic and histopathologic evaluation of women with HPV persistence exiting an organized screening program.
    Sahlgren H; Elfström KM; Lamin H; Carlsten-Thor A; Eklund C; Dillner J; Elfgren K
    Am J Obstet Gynecol; 2020 Mar; 222(3):253.e1-253.e8. PubMed ID: 31585095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
    Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
    Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-infection with trichomonas vaginalis increases the risk of cervical intraepithelial neoplasia grade 2-3 among HPV16 positive female: a large population-based study.
    Yang M; Li L; Jiang C; Qin X; Zhou M; Mao X; Xing H
    BMC Infect Dis; 2020 Sep; 20(1):642. PubMed ID: 32873233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High molecular prevalence of HPV and other sexually transmitted infections in a population of asymptomatic women who work or study at a Brazilian university.
    Suehiro TT; Gimenes F; Souza RP; Taura SKI; Cestari RCC; Irie MMT; Boer CG; Consolaro MEL; Silva VRSD
    Rev Inst Med Trop Sao Paulo; 2021; 63():e1. PubMed ID: 33503149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.
    Munro A; Gillespie C; Cotton S; Busby-Earle C; Kavanagh K; Cuschieri K; Cubie H; Robertson C; Smart L; Pollock K; Moore C; Palmer T; Cruickshank ME
    BJOG; 2017 Aug; 124(9):1394-1401. PubMed ID: 28102931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevalence of high-risk HPV and its distribution in cervical precancerous lesions among 35-64 years old women who received cervical cancer screening in Beijing].
    Shen J; Gao LL; Zhang Y; Han LL; Wang JD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 May; 52(5):493-497. PubMed ID: 29747341
    [No Abstract]   [Full Text] [Related]  

  • 31. Prevalence of sexually transmitted infections (Neisseria gonorrhoeae, Chlamydia trachomatis, Trichomonas vaginalis and human papillomavirus) in female attendees of a sexually transmitted diseases clinic in Ulaanbaatar, Mongolia.
    Garland SM; Tabrizi SN; Chen S; Byambaa C; Davaajav K
    Infect Dis Obstet Gynecol; 2001; 9(3):143-6. PubMed ID: 11516062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence.
    Frega A; Stentella P; De Ioris A; Piazze JJ; Fambrini M; Marchionni M; Cosmi EV
    Cancer Lett; 2003 Jul; 196(2):127-34. PubMed ID: 12860270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chlamydia trachomatis and human papillomavirus infection in Indian women with sexually transmitted diseases and cervical precancerous and cancerous lesions.
    Gopalkrishna V; Aggarwal N; Malhotra VL; Koranne RV; Mohan VP; Mittal A; Das BC
    Clin Microbiol Infect; 2000 Feb; 6(2):88-93. PubMed ID: 11168078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of the effectiveness of HPV16/18 infection referred for colposcopy in cervical cancer screening in Northwest of China.
    Zhang Q; Zhao M; Cao D; Wei X; Wang L; Li Y; Yang T; Zhao J; Pei M; Jia H; Cao S; Quan S; Yang X
    J Med Virol; 2018 Jan; 90(1):165-171. PubMed ID: 28710863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Analysis of related factors for cervical intraepithelial neoplasia Ⅱ
    Mao YN; You ZX
    Zhonghua Fu Chan Ke Za Zhi; 2021 Oct; 56(10):691-696. PubMed ID: 34823318
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevalence of cervical HPV infection, sexually transmitted infections and associated antimicrobial resistance in women attending cervical cancer screening in Mali.
    Jary A; Teguete I; Sidibé Y; Kodio A; Dolo O; Burrel S; Boutolleau D; Beauvais-Remigereau L; Sayon S; Kampo M; Traoré FT; Sylla M; Achenbach C; Murphy R; Berçot B; Bébéar C; Calvez V; Marcelin AG; Maiga AI
    Int J Infect Dis; 2021 Jul; 108():610-616. PubMed ID: 34146691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Influence of Human Papillomavirus Genotypes on Visual Screening and Diagnosis of Cervical Precancer and Cancer.
    Jeronimo J; Bansil P; Valdez M; Kang LN; Zhao FH; Qiao YL; Chen W; Zhang X; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    J Low Genit Tract Dis; 2015 Jul; 19(3):220-3. PubMed ID: 25279978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of sexually transmitted infections and human papillomavirus co-infection with abnormal cervical cytology among women in Saudi Arabia.
    Alotaibi HJ; Almajhdi FN; Alsaleh AN; Obeid DA; Khayat HH; Al-Muammer TA; Tulbah AM; Alfageeh MB; Al-Ahdal MN; Alhamlan FS
    Saudi J Biol Sci; 2020 Jun; 27(6):1587-1595. PubMed ID: 32489299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is human papillomavirus testing an effective triage method for detection of high-grade (grade 2 or 3) cervical intraepithelial neoplasia?
    Adam E; Kaufman RH; Berkova Z; Icenogle J; Reeves WC
    Am J Obstet Gynecol; 1998 Jun; 178(6):1235-44. PubMed ID: 9662307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of human papillomavirus and coinfection with other sexually transmitted pathogens on male infertility.
    Fan X; Xu Y; Xiang LF; Liu LP; Wan JX; Duan QT; Dian ZQ; Sun Y; Wu Z; Dong YH
    Asian J Androl; 2024 Sep; ():. PubMed ID: 39268811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.